ARCHIVES

Ungerleider To Leave NCI For Theradex Corp.

This article is from The Cancer Letter archive.

Vol. 26 No. 43 | November 24, 2000

Download PDF Visit The Full Archive

Related Articles

Wilms’ Tumor Survivors At High Risk Of Heart Failure

April 27, 2001

Gleevec Better Than Interferon For Newly Diagnosed CML

May 31, 2002

NCI-Approved Clinical Trials

July 30, 2010

IOM: Mammograms Still Best For Breast Cancer Detection.

March 16, 2001

In Brief: House Hearings On NIH Budget Begin Feb. 1; Army Program Is Peer Reviewing Proposals

January 28, 1994

White House Seek Elimination Of NCI’s Bypass Budget Authority In Legislation Renewing Cancer Act

April 9, 1982